Your session is about to expire
← Back to Search
PrEP Strategies for HIV Prevention (POWER Up Trial)
N/A
Recruiting
Led By Jessica Ridgway, MD, MS
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention, month 37
Awards & highlights
POWER Up Trial Summary
This trial will study strategies to increase PrEP use among Black cisgender women, to combat the higher incidence of HIV in this population.
Who is the study for?
This trial is for Black cisgender women aged 18 or older who are HIV-negative. It aims to increase the use of PrEP, a medication that prevents HIV infection. Women under 18 or those already living with HIV cannot participate.Check my eligibility
What is being tested?
The study tests four strategies: educating providers and patients about PrEP, optimizing electronic medical records (EMR) for better tracking, guiding patients through PrEP usage (navigation), and giving feedback to providers on their prescribing habits.See study design
What are the potential side effects?
Since this trial focuses on educational and procedural interventions rather than medications, there are no direct side effects from drugs being tested. However, participants may experience indirect effects related to changes in clinic procedures.
POWER Up Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-intervention, month 37
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention, month 37
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
PrEP uptake
Secondary outcome measures
Acceptability for patients
Acceptability for providers
Appropriateness
+17 morePOWER Up Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment5 Interventions
Implementation of 1) Patient Education, 2) Provider PrEP training, 3) EMR optimization, and 4) PrEP navigation, and the effect of these intervention components on the ability of each site to assess HIV risk/take a sexual history, assess PrEP eligibility, identify PrEP ineligibility for otherwise PrEP-eligible patients, provide PrEP education, offer PrEP, provide PrEP navigation, measure PrEP uptake, and measure PrEP persistence/retention.
Group II: Usual CareActive Control1 Intervention
The current mechanisms used at each healthcare site to assess HIV risk/ take a sexual history, assess PrEP eligibility, identify PrEP ineligibility for otherwise PrEP eligible patients, provide PrEP education, offer PrEP, provide PrEP navigation, measure PrEP uptake, and measure PrEP persistence/retention.
Find a Location
Who is running the clinical trial?
University of ChicagoLead Sponsor
1,004 Previous Clinical Trials
815,777 Total Patients Enrolled
AllianceChicagoOTHER
6 Previous Clinical Trials
13,181 Total Patients Enrolled
Rush UniversityOTHER
40 Previous Clinical Trials
380,018 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 years old.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the cap on participants for this research trial?
"Indeed, clinicaltrials.gov confirms that this trial is currently seeking out participants. The investigation was first published on August 10th 2023 and the details were last updated on 28th of August in the same year. A total of 4000 individuals are required at a single medical centre to partake in the study."
Answered by AI
Are fresh participants being accepted for this scientific exploration?
"As of today, this clinical trial is still actively searching for participants. The initial posting was on August 10th 2023 and the listing has been modified as recently as August 28th 2023."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger